Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus for Superficial KHE and TA
NCT04056962Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2019
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tacrolimus Ointment 0.1% Iwaki in kaposiform hemangioendothelioma (KHE), tufted angioma (TA), sponsored by West China Hospital of Sichuan University. Started Sep 2019; status: recruiting.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
kaposiform hemangioendothelioma (KHE)tufted angioma (TA)
Beyond the preview
Go deeper on NCT04056962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056962.